From Speed to Cures: Our Journey into the Life Sciences
At Salt, we believe in the power of technology to transform industries. We're taking that mission into one of humanity's most critical frontiers: life sciences and medical research.
Why Life Sciences Needs Modern AI Workflows
The challenges in medical research are uniquely complex. Researchers are processing enormous datasets, running computationally intensive simulations, and collaborating across multiple disciplines, all while racing against time to develop treatments that could save lives.
This is exactly the type of environment where Salt's workflow approach can make a profound difference.
Bringing Scientists and AI Together
Our team has partnered with the Ellison Medical Institute (EMI), led by renowned cancer researcher Dr. David Agus. In our initial work with the EMI team, we have already seen transformative results with de novo proteins.
“Since we met the team almost a year ago, Salt AI’s platform has helped us to innovate at rapid speed in designing new therapeutics for cancer,” said Dr. Agus. “By enabling research laboratories access to AI-powered drug design, Salt AI is accelerating timelines and scalability of cancer drug design.”
On the performance side, we have been able to run AlphaFold2 at speeds 22x faster than commercially available versions. While an incredible feat, this isn’t just a technical achievement, it embodies the crucial time saved in the research process.
By creating intuitive and collaborative AI workflows that connect research teams with cutting-edge models and powerful computing resources, we're helping to remove the technical barriers that often slow scientific progress and ultimately help bring potential treatments to the patients who need them.
Early Progress, Endless Potential
What excites us is Salt’s true collaboration between experts of different disciplines across the life sciences. Our platform's visualization capabilities mean biochemists, oncologists, other specialists, and beyond can engage with AI workflows in real-time, bringing their expertise directly into the drug discovery process. And we plan to bring this to the entire pharmaceutical lifecycle—from improving manufacturing efficiency through supply chain modeling to enhancing clinical development with real-world data analysis.
Our vision is about the impact our software makes. Every day saved in research is a day closer to new treatments reaching patients. And every barrier removed is an opportunity for a scientific breakthrough.
You can read our full press release and we invite you to learn more about Salt’s expansion into the life sciences at salt.ai.
